Adam Mendelsohn On Raising $100 Million To Develop A Portfolio Of Miniature, Long-Term Implants To Deliver Drugs More Efficiently And Consistently
In the bustling world of biotechnology and venture capital, few stories are as captivating as that of Adam Mendelsohn, the CEO of Vivani Medical. Adam’s journey demonstrates an inspiring blend of vision, perseverance, and adaptability required to navigate the complex landscape of building and scaling a company–particularly one that transitioned from a private entity to a publicly traded powerhouse. Adam's company, Vivani Medical, has attracted funding from top-tier investors like the National Institutes of Health.